168 related articles for article (PubMed ID: 7820405)
1. High dose rate versus low dose rate brachytherapy for squamous cell carcinoma of the cervix: an economic analysis.
Jones G; Lukka H; O'Brien B
Br J Radiol; 1994 Nov; 67(803):1113-20. PubMed ID: 7820405
[TBL] [Abstract][Full Text] [Related]
2. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
3. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
[TBL] [Abstract][Full Text] [Related]
4. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
5. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
6. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
Kim WC; Kim GE; Suh CO; Loh JJ
Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
[TBL] [Abstract][Full Text] [Related]
7. Case report: low dose rate and high dose rate intracavitary brachytherapy in a patient with carcinoma of the cervix.
Tan LT; Jones B; Freestone G; Dale RG
Br J Radiol; 1996 Jan; 69(817):84-6. PubMed ID: 8785631
[TBL] [Abstract][Full Text] [Related]
8. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
Tanaka E; Oh RJ; Yamada Y; Shiomi H; Nakamura S; Shimamoto S; Teshima T; Inoue T; Inoue T
Brachytherapy; 2003; 2(2):85-90. PubMed ID: 15062145
[TBL] [Abstract][Full Text] [Related]
10. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
[TBL] [Abstract][Full Text] [Related]
11. HDR and MDR intracavitary treatment for carcinoma of the uterine cervix. A prospective randomized study.
el-Baradie M; Inoue T; Inoue T; Murayama S; Tang JT; Yamazaki H; Fournier-Bidoz N
Strahlenther Onkol; 1997 Mar; 173(3):155-62. PubMed ID: 9122857
[TBL] [Abstract][Full Text] [Related]
12. Time-driven activity-based costing of low-dose-rate and high-dose-rate brachytherapy for low-risk prostate cancer.
Ilg AM; Laviana AA; Kamrava M; Veruttipong D; Steinberg M; Park SJ; Burke MA; Niedzwiecki D; Kupelian PA; Saigal C
Brachytherapy; 2016; 15(6):760-767. PubMed ID: 27720202
[TBL] [Abstract][Full Text] [Related]
13. Twice-per-day fractionated high versus continuous low dose rate intracavitary therapy in the radical treatment of cervical cancer: a nonrandomized comparison of treatment results.
Hsu WL; Wu CJ; Jen YM; Yen SH; Lin KT; Ger LP; Kim RY
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1425-31. PubMed ID: 7635783
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome of medium-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: comparison with low-dose-rate intracavitary brachytherapy.
Kaneyasu Y; Kita M; Okawa T; Maebayashi K; Kohno M; Sonoda T; Hirabayashi H; Nagata Y; Mitsuhashi N
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):137-45. PubMed ID: 22285665
[TBL] [Abstract][Full Text] [Related]
15. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
[TBL] [Abstract][Full Text] [Related]
16. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations.
Stitt JA; Fowler JF; Thomadsen BR; Buchler DA; Paliwal BP; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1992; 24(2):335-48. PubMed ID: 1526873
[TBL] [Abstract][Full Text] [Related]
17. Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer.
Shah C; Lanni TB; Ghilezan MI; Gustafson GS; Marvin KS; Ye H; Vicini FA; Martinez AA
Brachytherapy; 2012; 11(6):441-5. PubMed ID: 22728157
[TBL] [Abstract][Full Text] [Related]
18. Results and complications of high dose rate and low dose rate brachytherapy in carcinoma of the cervix: Cerrahpaşa experience.
Okkan S; Atkovar G; Sahinler I; Oner Dinçbaş F; Koca A; Köksal S; Turkan S; Uzel R
Radiother Oncol; 2003 Apr; 67(1):97-105. PubMed ID: 12758245
[TBL] [Abstract][Full Text] [Related]
19. Brachytherapy for stage IIIB squamous cell carcinoma of the uterine cervix: survival and toxicity.
Zuliani AC; Cunha Mde O; Esteves SC; Teixeira JC
Rev Assoc Med Bras (1992); 2010; 56(1):37-40. PubMed ID: 20339784
[TBL] [Abstract][Full Text] [Related]
20. Determination of the appropriate fraction number and size of the HDR brachytherapy for cervical cancer.
Liu WS; Yen SH; Chang CH; Yang KM; Wu YP; Chen KY
Gynecol Oncol; 1996 Feb; 60(2):295-300. PubMed ID: 8631555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]